Health
Oxford’s Covid-19 vaccine candidate is safe, early results show – Hindustan Times
The Lancet said the current trial is too preliminary to confirm whether the new vaccine meets these requirements, but phase 2 (in the UK only) and phase 3 trials to confirm whether it effectively protects against SARS-CoV-2 infection are happening in the UK, …
The vaccine candidate developed at the University of Oxford is safe and induces immune reaction, preliminary results published in medical journal The Lancet on Monday said, raising hopes for a cure for Covid-19 that has killed tens of thousands and disrupted human activity across the globe.
The widely-followed trial is currently at an advanced stage, with trials in the UK, Brazil and South Africa. A collaboration has already been reached between Oxford, UK government and biopharma major AstraZe…
-
General21 hours agoVote counting begins for Townsville mayoral by-election
-
General24 hours agoThree NT residents charged with fraud over alleged $71 million Defence contract scheme
-
Noosa News23 hours agoLGAQ motions become voice for community
-
Business13 hours agoNvidia’s quiet move into quantum computing could reshape the next frontier of AI